Why Iradimed Stock Topped the Market Today

Mechanical resonance imaging (MRI) equipment specialist Iradimed (NASDAQ: IRMD) ended the stock trading week in style on Friday. On the back of a well-received quarterly earnings report, investors traded the company's shares up by more than 4%. That was robust enough to trounce the 0.3% gain of the bellwether S&P 500 index that trading session.Iradimed posted its first-quarter figures that morning, and Mr. Market clearly liked what he saw. The company's top line expanded by 13% to just under $22 million, which exceeded the average analyst estimate of $20.8 million. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool